Search

Your search keyword '"Creed, T"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Creed, T" Remove constraint Author: "Creed, T"
107 results on '"Creed, T"'

Search Results

2. Activating STING1-dependent immune signaling inTP53mutant and wild-type acute myeloid leukemia

5. Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia.

6. P713 Effects of vedolizumab on health-related quality of life, work productivity and patient concerns in patients with ulcerative colitis and Crohn’s disease in the UK and Ireland: OCTAVO cohort 2

9. Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)

13. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial

14. HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants

15. The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis.

16. Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis

17. Reports Of Societies

19. Ustekinumab as induction and maintenance therapy for Crohn's disease

22. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease

24. Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis.

25. Glycolytic enzymes localize to ribonucleoprotein granules in Drosophila germ cells, bind Tudor and protect from transposable elements

28. Frontline Science: Tumor necrosis factor-a stimulation and priming of human neutrophil granule exocytosis

33. Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease

35. Should we monitor vitamin B12 levels in patients who have had end-ileostomy for inflammatory bowel disease?

36. PWE-056 Single centre experience of vedolizumab in the management of moderate to severe ulcerative colitis and crohn’s disease

37. DNA Demethylating Agents Generate a Brcaness Effect in Multiple Sporadic Tumor Types: Prediction for Sensitivity to PARP Inhibitors in AML

40. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

41. Unveiling errors in soil microbial community sequencing: a case for reference soils and improved diagnostics for nanopore sequencing.

42. Multi-label Multi-task Deep Learning for Behavioral Coding.

43. The Structure of Competence: Evaluating the Factor Structure of the Cognitive Therapy Rating Scale.

44. A Non-randomized Comparison of Strategies for Consultation in a Community-Academic Training Program to Implement an Evidence-Based Psychotherapy.

45. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.

46. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

47. System-Level Influences on the Sustainability of a Cognitive Therapy Program in a Community Behavioral Health Network.

48. Sexual trauma history does not moderate treatment outcome in Attachment-Based Family Therapy (ABFT) for adolescents with suicide ideation.

49. Novel role of specific Tudor domains in Tudor-Aubergine protein complex assembly and distribution during Drosophila oogenesis.

50. Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome.

Catalog

Books, media, physical & digital resources